The Conversation: AI has the potential to revolutionise healthcare – but we must first confront the risk of algorithmic bias
AI algorithms may have inherent biases that could lead to discrimination.
Stay updated with breaking news from Clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AI algorithms may have inherent biases that could lead to discrimination.
Issuer: Immunic, Inc. / Key word(s): Study results Immunic Reports Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease, Providing Clinical Proof-of-Concept for New Therapeutic Approach to Gastrointestinal Disorders 04.05.2023 / 12:30 CET/CEST The issuer is solely responsib...
Governor Brian Kemp signed SB223 into law Tuesday.
Superb batting show followed by collective bowling performance helped Lucknow Super Giants (LSG) hammer Punjab...
Global biopharmaceutical company GlaxoSmithKline is scheduled to submit market approvals in China for about 15 new drugs and indications over the next three years and more than 20 clinical research projects will be conducted in the country, said a senior executive of the company.